Table 2 Relationship between CHPF expression and tumor characteristics in patients with malignant melanoma.
Features | No. of patients | CHPF expression | p value | |
|---|---|---|---|---|
low | high | |||
All patients | 86 | 38 | 48 | |
Age (years) | 0.360 | |||
<51 | 41 | 16 | 25 | |
≥51 | 45 | 22 | 23 | |
Gender | 0.629 | |||
Male | 41 | 17 | 24 | |
Female | 45 | 21 | 24 | |
T infiltrate | 0.037* | |||
T1 | 6 | 4 | 2 | |
T2 | 16 | 11 | 5 | |
T3 | 3 | 0 | 3 | |
T4 | 61 | 23 | 38 | |
lymphatic metastasis (N) | 0.941 | |||
N0 | 79 | 35 | 44 | |
N1 | 7 | 3 | 4 | |
Stage | 0.097 | |||
I | 12 | 9 | 3 | |
II | 65 | 25 | 40 | |
III | 8 | 4 | 4 | |
IV | 1 | 0 | 1 | |
